- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Accommodating IOL receives NTIOL classification
An accommodating IOL with aspheric optics (Crystalens AO, Bausch + Lomb) has received new-technology IOL classification from the Centers for Medicare and Medicaid Services.
Aliso Viejo, CA
-An accommodating IOL with aspheric optics (Crystalens AO, Bausch + Lomb) has received new-technology IOL (NTIOL) classification from the Centers for Medicare and Medicaid Services (CMS).
The classification became effective April 9 and means that the lens is approved for an additional $50 Medicare payment adjustment for services in conjunction with cataract procedures performed at ambulatory surgical centers.
“We are pleased that the [lens] has been included into the active NTIOL class for reduced spherical aberration,” said Andy Corley, global president, Surgical, Bausch + Lomb. “We believe that this decision should benefit surgeons and their patients in the coming months."
